4
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-045444
Chief Executive Officer bought 1,175 shares at $6.06 ($7,116)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-12 | Purchase : show line 1 in the form | +1,175 | $6.06 | $7,116 | 65,360 | D |
| Open-market purchases · 1,175 sh · avg $6.06 · $7,116 | ||||||
Loading xslF345X03/doc4.xml…